Home
About Us
About ReNeuron
Board of Directors
Senior Management
Advisory Board
Working at ReNeuron
Patents
Products
Our Products & Technologies
hRPCs for Retinal Disease
CTX cells for Stroke Disability
CTX-derived Exosomes
Induced pluripotent stem cell (iPSC) Platform
ReNcell Products
Publications
Clinical Trials
Clinical Trials
Phase I/IIa clinical trial in retinitis pigmentosa
Phase IIb Clinical trial in stroke disability (PISCES III)
Phase IIa clinical trial in stroke disability (PISCES-II)
Phase I clinical trial in stroke disability (PISCES)
Observational study in stroke
News
News Centre
News
Events
Media Coverage
Investors
Investor Centre
Corporate Governance
Share Price Information
Major Shareholdings
Advisors
Analyst Research
Financial Reports
General Meetings
Webcasts and Presentations
Financial Calendar
Email alerts
RNS Notifications
Documents and Circulars
AIM Rule 26
Declarations
Contact
Contact Us
Home
About Us
About ReNeuron
Board of Directors
Senior Management
Advisory Board
Working at ReNeuron
Patents
Products
Our Products & Technologies
hRPCs for Retinal Disease
CTX cells for Stroke Disability
CTX-derived Exosomes
Induced pluripotent stem cell (iPSC) Platform
ReNcell Products
Publications
Clinical Trials
Clinical Trials
Phase I/IIa clinical trial in retinitis pigmentosa
Phase IIb Clinical trial in stroke disability (PISCES III)
Phase IIa clinical trial in stroke disability (PISCES-II)
Phase I clinical trial in stroke disability (PISCES)
Observational study in stroke
News
News Centre
News
Events
Media Coverage
Investors
Investor Centre
Corporate Governance
Share Price Information
Major Shareholdings
Advisors
Analyst Research
Financial Reports
General Meetings
Webcasts and Presentations
Financial Calendar
Email alerts
RNS Notifications
Documents and Circulars
AIM Rule 26
Declarations
Contact
Contact Us
Share Price Information
Chart
Investment calculator
Share price look-up
Share series
Section: Investors
The financial year in review to March 2020
The financial year in review to March 2019
Email alerts
General Meetings
Investor Centre
Corporate Governance
Share Price Information
Major Shareholdings
Advisors
Analyst Research
Webcasts and Presentations
Financial Reports
Financial Calendar
RNS Notifications
Documents and Circulars
AIM Rule 26
Declarations